What does PHARMACIE STASSEN-BYA do?

PHARMACIE STASSEN-BYA is a pharmacy in Juprelle. Private Limited, started on 6 March 2002, 1 establishment.

What is the address of PHARMACIE STASSEN-BYA?

The registered office of PHARMACIE STASSEN-BYA is located at Rue Provinciale 629, 4450 Juprelle.

Is PHARMACIE STASSEN-BYA still active?

Yes. According to the CBE (31 October 2026) PHARMACIE STASSEN-BYA is active, legal situation “Normale toestand”, started on 6 March 2002.

Is PHARMACIE STASSEN-BYA registered on Peppol?

Yes, PHARMACIE STASSEN-BYA is registered on the Peppol network with ID 0208:0477017987.

What is the enterprise number of PHARMACIE STASSEN-BYA?

The enterprise number of PHARMACIE STASSEN-BYA is BE0477017987.

When was PHARMACIE STASSEN-BYA founded?

PHARMACIE STASSEN-BYA was founded on 6 March 2002.

Who are the directors of PHARMACIE STASSEN-BYA?

According to the 2025 annual accounts, the directors of PHARMACIE STASSEN-BYA are: Renée STASSEN, Renaud BYA.

Is PHARMACIE STASSEN-BYA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 March 2002; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE STASSEN-BYA make in 2025?

PHARMACIE STASSEN-BYA posted a profit after taxes of € 90,044 in financial year 2025.

What is the revenue of PHARMACIE STASSEN-BYA?

As a small company, PHARMACIE STASSEN-BYA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 352,351.

How much does an employee at PHARMACIE STASSEN-BYA earn?

The average wage cost per full-time employee at PHARMACIE STASSEN-BYA was € 60,300 in 2025: staff costs of € 144,702 for 2.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE STASSEN-BYA have?

According to the 2025 annual accounts, PHARMACIE STASSEN-BYA has 2.4 full-time equivalents (FTE).

Does PHARMACIE STASSEN-BYA have a website?

Yes, PHARMACIE STASSEN-BYA has a website at pharmastassen.be.

PHARMACIE STASSEN-BYA (Private Limited) - Juprelle

Dossier PHARMACIE STASSEN-BYA, printed on 31 October 2026 from databakkes.be/en/0477017987/pharmacie-stassen-bya. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 2.9 to 2.4.

Financials

Financial year 2025

PHARMACIE STASSEN-BYA from Juprelle, company number BE0477017987, closed financial year 2025 with a result of € 90,044 after tax. For that financial year PHARMACIE STASSEN-BYA recorded a gross margin of € 352,351 and equity of € 580,595. Compared with financial year 2024, the result moved from € 90,595 to € 90,044. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 580,595

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 90,044

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 338,976

▲ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 63,666 paid out

71 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

2.4

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 144,702

▼ 7% vs 2024

€ 60,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 12,963

▼ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 312,456

▼ 11% vs 2024

€ 41,019 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 81,349

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 40,357

▲ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 306,830 Gross margin 2022: € 306,830 First fiscal year in the series	€ 350,962 Gross margin 2023: € 350,962 ▲ 14% vs 2022 (€ 306,830) Favourable step	€ 366,800 Gross margin 2024: € 366,800 ▲ 5% vs 2023 (€ 350,962) Favourable step	€ 352,351 Gross margin 2025: € 352,351 ▼ 4% vs 2024 (€ 366,800) Unfavourable step	▼ 4%
Profit after taxes	€ 69,033 Profit after taxes 2022: € 69,033 First fiscal year in the series	€ 91,821 Profit after taxes 2023: € 91,821 ▲ 33% vs 2022 (€ 69,033) Favourable step	€ 90,595 Profit after taxes 2024: € 90,595 ▼ 1% vs 2023 (€ 91,821) Unfavourable step	€ 90,044 Profit after taxes 2025: € 90,044 ▼ 1% vs 2024 (€ 90,595) Unfavourable step	▼ 1%
Equity	€ 550,769 Equity 2022: € 550,769 First fiscal year in the series	€ 510,340 Equity 2023: € 510,340 ▼ 7% vs 2022 (€ 550,769) Unfavourable step	€ 554,217 Equity 2024: € 554,217 ▲ 9% vs 2023 (€ 510,340) Favourable step	€ 580,595 Equity 2025: € 580,595 ▲ 5% vs 2024 (€ 554,217) Favourable step	▲ 5%
Total debts	€ 702,997 Total debts 2022: € 702,997 First fiscal year in the series	€ 833,565 Total debts 2023: € 833,565 ▲ 19% vs 2022 (€ 702,997) Unfavourable step	€ 638,223 Total debts 2024: € 638,223 ▼ 23% vs 2023 (€ 833,565) Favourable step	€ 595,230 Total debts 2025: € 595,230 ▼ 7% vs 2024 (€ 638,223) Favourable step	▼ 7%
Cash	€ 515,356 Cash 2022: € 515,356 First fiscal year in the series	€ 587,034 Cash 2023: € 587,034 ▲ 14% vs 2022 (€ 515,356) Favourable step	€ 307,123 Cash 2024: € 307,123 ▼ 48% vs 2023 (€ 587,034) Unfavourable step	€ 338,976 Cash 2025: € 338,976 ▲ 10% vs 2024 (€ 307,123) Favourable step	▲ 10%
Land & buildings	€ 451,791 Land & buildings 2022: € 451,791 First fiscal year in the series	€ 423,435 Land & buildings 2023: € 423,435 ▼ 6% vs 2022 (€ 451,791) Unchanged	€ 395,080 Land & buildings 2024: € 395,080 ▼ 7% vs 2023 (€ 423,435) Unchanged	€ 366,725 Land & buildings 2025: € 366,725 ▼ 7% vs 2024 (€ 395,080) Unchanged	▼ 7%
Retained profit	€ 513,569 Retained profit 2022: € 513,569 First fiscal year in the series	€ 473,140 Retained profit 2023: € 473,140 ▼ 8% vs 2022 (€ 513,569) Unfavourable step	€ 517,017 Retained profit 2024: € 517,017 ▲ 9% vs 2023 (€ 473,140) Favourable step	€ 543,395 Retained profit 2025: € 543,395 ▲ 5% vs 2024 (€ 517,017) Favourable step	▲ 5%
Dividend	€ 127,600 Dividend 2022: € 127,600 First fiscal year in the series	€ 132,250 Dividend 2023: € 132,250 ▲ 4% vs 2022 (€ 127,600) Unchanged	€ 46,718 Dividend 2024: € 46,718 ▼ 65% vs 2023 (€ 132,250) Unchanged	€ 63,666 Dividend 2025: € 63,666 ▲ 36% vs 2024 (€ 46,718) Unchanged	▲ 36%
Bank debt	€ 126,050 Bank debt 2022: € 126,050 First fiscal year in the series	€ 102,732 Bank debt 2023: € 102,732 ▼ 18% vs 2022 (€ 126,050) Favourable step	€ 349,144 Bank debt 2024: € 349,144 ▲ 240% vs 2023 (€ 102,732) Unfavourable step	€ 312,456 Bank debt 2025: € 312,456 ▼ 11% vs 2024 (€ 349,144) Favourable step	▼ 11%
Balance sheet total	€ 1,253,765 Balance sheet total 2022: € 1,253,765 First fiscal year in the series	€ 1,343,905 Balance sheet total 2023: € 1,343,905 ▲ 7% vs 2022 (€ 1,253,765) Unchanged	€ 1,192,440 Balance sheet total 2024: € 1,192,440 ▼ 11% vs 2023 (€ 1,343,905) Unchanged	€ 1,175,825 Balance sheet total 2025: € 1,175,825 ▼ 1% vs 2024 (€ 1,192,440) Unchanged	▼ 1%
Employees (FTE)	2.8 Employees (FTE) 2022: 2.8 First fiscal year in the series	2.9 Employees (FTE) 2023: 2.9 ▲ 0.1 vs 2022 (2.8) Unchanged	2.8 Employees (FTE) 2024: 2.8 ▼ 0.1 vs 2023 (2.9) Unchanged	2.4 Employees (FTE) 2025: 2.4 ▼ 0.4 vs 2024 (2.8) Unchanged	▼ 0.4

Key figures of PHARMACIE STASSEN-BYA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE STASSEN-BYA?

What happened at PHARMACIE STASSEN-BYA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 90,044 (▼ 1% vs 2024). Source: NBB ↗
May 2, 2002 New establishment in Juprelle. KBO
Mar 6, 2002 Start of the company according to the CBE. KBO

In short

From € 69,033 profit in 2022 to € 90,044 profit in 2025.

Paid € 137,012 in corporate taxes since 2022.

Best year ever: 2023, with € 91,821 profit.

On average € 146,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Renée STASSEN Renaud BYA

PHARMACIE STASSEN-BYA

Behind PHARMACIE STASSEN-BYA are Renée STASSEN and Renaud BYA.

Directors

According to the 2025 annual accounts

Renée STASSEN

Director

Renaud BYA

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Provinciale 629

4450 Juprelle

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmastassen.be

Technologies

AMPAdobe FontsAlpine.jsCookie ConsentGoogle FontsGoogle TranslateNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Proximus Mail

Hosting

UPCLOUD, FI

DNS

Cloudflare DNS

Domain

pharmastassen.be

Registered

2016-10-18

Website info

HTTPS Ja

Indexable pages 56,001

Languages FR

Features

Webshop Newsletter Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0477.017.987

VAT number

BE 0477.017.987

Registered office

Rue Provinciale 629, 4450 Juprelle

Names & denominations

PHARMACIE STASSEN-BYA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 March 2002

Peppol

Active · Active since 25 Nov 2025

Contact

pharmastassen.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Managementactiviteiten van holdings

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE STASSEN-BYA

Warning lights

Financials

What happened to PHARMACIE STASSEN-BYA?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions